News and Comments

ILMN AND HGSI: REASONS FOR ATYPICAL REJECTIONS OF TAKEOVERS

  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...

AFFYMAX vs. AMGEN?

  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...


Recent Postings


Archive


Tags

ZALTRAP™ Anacor (ANAC) Vertex (VRTX) CompuGen (CGEN) ImmunoGen (IMGN) Sanofi (SNY) GlaxoSmithKline (GSK) IDERA (IDRA) GUARDIAN HEALTH Human Genome Sciences (HGSI) Biocryst (BCRX) ABBVIE (ABBV) Vitae Pharmaceuticals (VTAE) Agenus (AGEN Ariad (ARIA) Cytokinetics (CYTK) Abbott Laboratories (ABT) Intrexon (XON) TOKAI (TKAOI) Inovio (INO) Biogen Idec (BIIB) Amgen (AMGN) KITE (KITE) Elan (ELN) SUNESIS PHARMACEUTICALS (SNSS) C4 Therapeutics Regeneron (REGN) Intermune (ITMN) Gilead (GILD) Theravance Bio Pharma (TBPH) Aimmune Therapeutics (AIMT) Telaprevir VANDA (VNDA) Herceptin SERES THERAPEUTICS (MCRB) Tysabri ISIS (ISIS) Human Longevity (HLI) Ridaforolimus Array Pharmaceuticals (ARRY) Roche (RHHBY) Theravance (THRX) Velcade (bortezomib) JUNO (JUNO) Dynavax (DVAX) Illumina (ILMN) SYNTA (SNTA) Ionis (IONS) Prosensa (RNA) OSI (OSIP) Mirati Therapeutics (MRTX) KERYX (KERX) ACADIA (ACAD) ARCA (ABIO) ADVENTRIX (ANX) Benlysta (belimumab) Sarepta (SRPT) BIOMARIN (BMRN) AERIE PHARMACEUTICALS Seattle Genetics (SGEN) Valeant Pharmaceuticals International (VRX) Dendreon (DNDN) Multiple Myeloma Sequenom (SQNM) galapagos (GLPG) Trastuzumab-DM1 Alnylam (ALNY) Roche (ROCHE) Anadys (ANDS) Genentech Jazz Pharmaceuticals (JAZZ) Merck (MRK) Endometrial Cancer Revlimid (lenolidamide) Intercept (ICPT) Galena (GALE) Alder Biopharmaceuticals (ALDR) Micromet (MITI) Rapamune NEKTAR (NKTR)) Incyte (INCY) NANTKWEST (NK) Exelixis (EXEL) Ziofpharm (ZIOP) REGULUS (RGLS) Xoma (XOMA) Idenix (IDIX) Onyx (ONXX) Bristol-Myers Squibb (BMY) Sanofi-Aventis (SAN) Auspex (ASPX) Prolor Biotech (PBTH) Sanofi (SNA) Pluristem (PSTI) Agenus (AGEN) Sangamo (SGMO) Zerenex HALOZYME (HALO)